Overview
Body Locations and Systems
Disorders and Conditions
ClinicalTrials.gov#
NCT03112603
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Claudia Piechnik, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to assess the efficacy of ruxolitinib against best available therapy in participants with steroid-refractory chronic graft-versus-host disease (SR cGvHD).
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Body Locations and Systems
Disorders and Conditions
ClinicalTrials.gov#
NCT03112603
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Claudia Piechnik, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to assess the efficacy of ruxolitinib against best available therapy in participants with steroid-refractory chronic graft-versus-host disease (SR cGvHD).
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.